Title |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study
|
---|---|
Published in |
Reproductive Health, April 2014
|
DOI | 10.1186/1742-4755-11-33 |
Pubmed ID | |
Authors |
Jesus Hernandez-Juarez, Ethel A Garcia-Latorre, Manuel Moreno-Hernandez, Jose Fernando Moran-Perez, Miguel Angel Rodriguez-Escobedo, Gerardo Cogque-Hernandez, Rubén Julián-Nacer, Xochitl Hernandez-Giron, Rosalia Palafox-Gomez, Irma Isordia-Salas, Abraham Majluf-Cruz |
Abstract |
The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects on Mexican population are unknown. The objective of the study was to evaluate if these treatments induce metabolic changes in a sample of indigenous and mestizo Mexican women. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Canada | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 49 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 16% |
Researcher | 7 | 14% |
Student > Postgraduate | 3 | 6% |
Student > Master | 3 | 6% |
Professor | 2 | 4% |
Other | 5 | 10% |
Unknown | 21 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 20% |
Biochemistry, Genetics and Molecular Biology | 4 | 8% |
Nursing and Health Professions | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
Business, Management and Accounting | 1 | 2% |
Other | 5 | 10% |
Unknown | 23 | 47% |